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Identity 
Alias: Howell-Evans syndromes; Tylosis oesophageal 
cancer; Focal non epidermolytic palmoplantar 
keratoderma (NEPPK) with carcinoma of the 
oesophagus 
Note: Synonyms include: (a) Tylosis oesophageal 
cancer or (b) Focal Non Epidermolytic Palmoplantar 
Keratoderma (NEPPK) with carcinoma of the 
oesophagus (Howel-Evans et al., 1958; Stevens et al., 
1996). 
Inheritance: Is a rare autosomal dominant condition 
with full penetrance of skin phenotype by puberty. No 
race prevalence has been noted (Howel-Evans et al., 
1958). 
Clinics 
Phenotype and clinics 
Tylosis is divided into to types: Type A with late onset 
of NEPPK between age of 5 to 15 years and Type B 
with early onset around the first year of age (Maillefer 
and Greydanus, 1999; Nagai et al., 2000).  
It usually involves the pressure areas mainly sole of 
feet and later mild involvement of palms (more obvius 
in manual workers). It can also affect frictional are s 
like elbows and knees. It regresses completely on bed 
rest (Howel-Evans et al., 1958; Stevens et al., 1996).  
The affected skin has a thickened epidermis which 
sheds horny large flakes, usually in autumn, to leave  
red tender surface which quickly get covered with 
another thick layer of epidermis (Howel-Evans et al.,
1958). 
Oral leukokeratosis (which are white "spongy" plaques) 
and follicular hyperkeratosis (which are pinkish-to-tan  
papules) on the body and flexure areas, are often se
in patients with tylosis and it could be a possible 
indication for developing oesophageal cancer (Tyldesly 
and Osborne-Hughes, 1973; Tyldesly, 1974). 
See example of Tylosis on DermAtlas. 
Neoplastic risk 
Malignancy Risk: Type A has a higher risk of 
developing squamous oesophageal carcinoma up to 
95% by age of 65 years, while Type B runs a benign 
course (Howel-Evans et al., 1958; Ellis et al., 1994; 
Stevens et al., 1996). 
These malignancies are predominantly in the distal 
esophagus whereas acquired squamous cell carcinomas 
are mostly mid-thoracic in location (Howel-Evans et 
al., 1958; Maillefer and Greydanus, 1999). Increase 
risk has been noted with history of smoking (Stevens t 
al., 1996).  
Histological findings: Thickening of the all skin layers 
especially epidermis, hypertrophy of sweat glands and
their ducts which often occluded by hyperplastic 
epithelium (Howel-Evans et al., 1958). 
Treatment 
Monitoring: Annual endoscopic surveillance with 
biopsies taken should be offered to affected individuals 
in view of risk of oesophageal cancer (Robertson et al., 
2008). 
Prognosis 
Prognosis of squamous cell cancer of oesophagus: In 
general is poor with 5 year survival of 75% in Stage 0 
(intraepithelial cancer) to <5% in stage IV (Distant 
metastasis). Overall survival is about 20-25% (Mayer, 
2001). 
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Cytogenetics 
Note 
The tylosis oesophageal cancer gene (TOC) is localized 
to a small region on band 17q25, a region frequently 
deleted in persons with sporadic squamous cell 
oesophageal tumours (Kelsell et al., 1996; Risk et al., 
2002). 
This region contains 5'end of uncharacterized (FM8) 
gene, which is likely non coding RNA, a promoter of 
another gene and the whole cytoglobin gene (Langan et 
al., 2004).  
So far studies has failed to identify TOC specific 
mutations in any of the 3 genes above (Langan et al., 
2004). 
However recent studies of the gene expression in the 
42.5 kb TOC minimal region has shown down 
regulation of cytoglobin gene expression by 70% in 
tylotic patients which might contribute to TOC 
phenotype. This reduction exceeds the expected 50% 
effect from autosomal dominant conditions therefore 
rules out a simple haplo-insufficiency as a mechanism 
of the disease, instead a novel trans-allele interac ion 
(ie the mutated allele causing suppression of the normal 
allele) has been suggested (McRonald et al., 2006). 





TOC gene or tylosis with oesophageal cancer gene. 
DNA/RNA 
Note: Abnormality in this area has been noted in breast 
and ovarian cancer (Nagai et al., 2000; Harada et al., 
2001). 
Description: 42.5kb.  
No mutations have been identified in the gene. 
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